ArticleFrontiers in medicine2026
Efficacy and safety of 2 Hz versus 100 Hz electroacupuncture for pain-dominant shoulder periarthritis: a study protocol for a single-center randomized controlled trial.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pain-dominant shoulder periarthritis is characterized by shoulder pain, restricted range of motion (ROM), and impaired daily function. Electroacupuncture (EA) is a controllable acupuncture modality used for shoulder pain disorders; however, direct evidence comparing 2 Hz and 100 Hz EA in this disease stage remains limited. Objective: This study aims to compare the efficacy and safety of low-frequency EA (2 Hz) and high-frequency EA (100 Hz) for pain-dominant shoulder periarthritis. Methods: This is a single-center, participant- and outcome assessor-blinded, parallel-group randomized controlled trial (RCT) to be conducted at the Third Clinical Hospital Affiliated to Changchun University of Chinese Medicine. A total of 152 participants who meet the diagnostic criteria for pain-dominant shoulder periarthritis and the traditional Chinese medicine (TCM) meridian differentiation criteria for the Hand Shaoyang meridian pattern will be enrolled. Participants will be randomly assigned in a 1:1 ratio to the 2 Hz EA group or the 100 Hz EA group. Both groups will receive the same acupuncture prescription, treatment procedures, and co-interventions, with EA frequency as the only planned between-group difference. Treatment will be administered once daily for 5 consecutive days per course, with a 2-day interval between courses, for a total of 10 sessions. Outcomes will be assessed at baseline and at 2, 8, and 24 weeks after treatment initiation. The primary outcome will be overall shoulder pain intensity measured using a 10-cm visual analog scale (VAS) at T1. The primary comparison will be the adjusted mean difference in the T1 overall VAS score between the two groups, with baseline overall VAS included as a covariate. Secondary outcomes will include component-specific VAS ratings for resting pain, activity-related pain, and nocturnal pain, the Shoulder Pain and Disability Index (SPADI), the Constant-Murley Score (CMS), and shoulder ROM. Adverse events (AEs) and serious adverse events (SAEs) will be recorded throughout the study. Discussion: This trial may provide clinical evidence to inform EA frequency selection and parameter standardization for pain-dominant shoulder periarthritis. Clinical trial registration: International Traditional Medicine Clinical Trial Registry, https://itmctr.ccebtcm.org.cn, identifier ITMCTR2026000862.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.